RSS


FC Member Blog

Ron Pollack: Recollections of a short seller

BY Ron PollackSat Oct 4, 2008 at 2:16 PM
This blog is written by a member of our blogging community and expresses that member's views alone.

We sat down with Ron Pollack, short-seller and hedge fund manager of
the former Dancing Bear (net short) Fund, and asked him about some of
his experiences as a short seller.  Ron recounted a story of a company
that he said was an example of a “technology hype story”.  Years ago
there was a laser company that supposedly had developed a better
ophthalmic laser for correcting various vision disorders.  This type of
product had been the subject of a lot of controversy at the time due to
the relatively low sales volume of the industry leader.  One question
had to do with the entire product category:  since the industry leader
had only been given FDA approval for certain limited indications, it
was too early to say whether the category would ever live up to
expectations that it would become the solution-of-choice for
nearsightedness, farsightedness, astigmatism, etc.  For the laser
company, however, there was an even bigger question:  Did they have a
viable product?  They said that they did: one that was smaller, less
expensive, safer and more effective than those of the industry leader
and other competitors.  But, in spite of the hype, the laser company
had yet to provide clinical data that supported their claims.  In fact,
at one of the meetings of ophthalmologists, the company was openly
chastised by skeptical doctors tired of hearing all sorts of promises
from the company with no proof.  The company had said that they had
widespread success with their laser in China. Well, Ron’s analyst found
a leading Chinese doctor who sat on key government councils, and got a
much different story.  The Chinese doctor told the analyst that many of
the company’s lasers that had been sent to China were either sitting in
boxes, unused and unpaid for, or were being sent back.  To top it all
off, the laser company was being sued by the industry leader and
another competitor for patent infringement.  It took a while for the
hype to yield to truth; but eventually it did, the stock cracked and
the company was delisted.

Topics:

Management, ron pollack, short sales, China, Ron Pollack, Food and Drug Administration, Health and Fitness, Eyesight and Eye Health


Sign in or register to comment.
or